Skip to main content
. 2020 Jan 9;26(2):196–208. doi: 10.3350/cmh.2019.0012

Figure 1.

Figure 1.

Patient selection flowsheet. HCC, hepatocellular carcinoma; HCV, hepatitis C virus; EIA, enzyme linked immunosorbant assay; PBC, primary biliary cirrosis; AIH, autoimmune hepatitis; ASH, alcoholic steatohepatitis; NASH, non-alcoholic steatohepatitis.